GlassScriptPhysician profile
Chris Hung Vu
NPI 1215466768
$734.89
in general payments reported to CMS, 2019-2025
12 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $28.86 · 2021: $19.07 · 2022: $111 · 2024: $219 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $143.34 | 2019-2022 | |
| Stryker Corporation | $122.71 | 2024-2025 | Augment Injectable, Hoffmann, Prostep Mica |
| Smith+Nephew, INC. | $121.89 | 2022-2024 | Grafix Pl, Renasys Go V2 Home |
| Integra Lifesciences Corporation | $117.36 | 2019-2025 | Integra, Micromatrix, Primatrix |
| Biotissue Holdings INC. | $73.91 | 2022 | |
| Paratek Pharmaceuticals, INC. | $34.75 | 2024 | Nuzyra |
| Amgen INC. | $25.17 | 2025 | Krystexxa |
| Abbvie INC. | $22.77 | 2025 | |
| Sun Pharmaceutical Industries INC. | $19.07 | 2021 | |
| Kerecis Limited | $18.83 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Convatec INC. | $18.08 | 2025 | |
| Ets Wound Care LLC | $17.01 | 2025 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.